Invention Application
- Patent Title: MULTIMERIC SARS-COV-2 BINDING MOLECULES AND USES THEREOF
-
Application No.: US17671837Application Date: 2022-02-15
-
Publication No.: US20220267415A1Publication Date: 2022-08-25
- Inventor: Zhiqiang KU , Xuping XIE , Paul HINTON , Ningyan ZHANG , Bruce KEYT , Dean NG , Stephen CARROLL , Pei-Yong SHI , Zhiqiang AN
- Applicant: The Board of Regents of The University of Texas System , IGM Biosciences, Inc.
- Applicant Address: US TX Austin; US CA Mountain View
- Assignee: The Board of Regents of The University of Texas System,IGM Biosciences, Inc.
- Current Assignee: The Board of Regents of The University of Texas System,IGM Biosciences, Inc.
- Current Assignee Address: US TX Austin; US CA Mountain View
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61P31/14
Abstract:
This disclosure provides multimeric binding molecules that bind to SARS-CoV-2. This disclosure also provides compositions comprising the multimeric binding molecules, polynucleotides that encode the multimeric binding molecules, and host cells that can produce the binding molecules. Further this disclosure provides methods of using the multimeric binding molecules, including methods for treating and preventing coronavirus disease 2019 (COVID-19).
Information query
